<![CDATA[Toxicity Management and Quality of Life Considerations for Patients with HER2-Positive Metastatic Breast Cancer]]>

Multimodal Exercise and Education Program in Metastatic Breast CancerMostrar más líneas

Conditions : Metastatic Breast Cancer; Cancer-Related Fatigue; Quality of Life Interventions : Other: Multimodal Oncology-Based Intervention

<![CDATA[From Observation to Treatment: The Role of Caregivers and Overcoming VMAT2 Inhibitor Complexities]]>

Methylation-based ctDNA monitoring in metastatic breast cancer during CDK4/6 inhibitor therapy

Methylation-based ctDNA monitoring in 57 patients closely reflects outcomes in ER+, HER2- metastatic breast cancer during CDK4/6 inhibitor t

Personalized Treatment Strategies for HER2-Positive Gastroesophageal Adenocarcinoma

Stay current with evolving strategies for HER2-positive gastroesophageal adenocarcinoman (GEA). Improve your practice with continuing educat

Ribociclib Plus Aromatase Inhibitor Delays Postprogression Events in HR+/HER2− Metastatic Breast Cancer

For patients with hormone receptor-positive, HER2-negative metastatic breast cancer, endocrine therapy combined with a CDK4/6 inhibitor has

Research on AI Models for Predicting Breast Cancer Treatment Effectiveness to Guide Her-2 Targeted ADC Therapy

Conditions : Breast Cancer Sponsors : Zhejiang Cancer Hospital Not yet recruiting